4.4 Article

Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination

期刊

GUT PATHOGENS
卷 9, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/s13099-017-0158-0

关键词

TLR1; TLR2; TLR6; Candida albicans; E. coli; Colitis

资金

  1. FP7 Health ALLFUN Project Fungi in the setting of inflammation, allergy and auto-immune diseases: translating basic science into clinical practices [260338]
  2. Swiss National Science Foundation [320030_149511, 310030_138488]
  3. Faculty of Biology and Medicine from the University of Lausanne
  4. Swiss National Science Foundation (SNF) [310030_138488, 320030_149511] Funding Source: Swiss National Science Foundation (SNF)

向作者/读者索取更多资源

Background: Toll-like receptors (TLRs) are the major pattern recognition receptors that mediate sensing of a wide range of microorganisms. TLR2 forms heterodimers with either TLR1 or TLR6, broadening its ligand diversity against pathogens. TLR1, TLR2 and TLR6 have been implicated in the recognition of Candida albicans, an opportunistic fungal pathogen that colonizes the gastrointestinal tract. In this study, we explored whether the deficiency in TLR1, TLR2 or TLR6 impacts C. albicans colonization and inflammation-associated colonic injury in the dextran sulfate sodium (DSS)-induced colitis in mice. Results: DSS treatment and C. albicans challenge induced greater weight loss, worse clinical signs of inflammation, higher histopathologic scores, and increased mortality rates in TLR1(-/-) and TLR2(-/-) mice when compared to TLR6(-/-) and wild-type mice. The number of C. albicans colonies in the stomach, colon and feces was decreased in TLR6(-/-) mice as compared to TLR2(-/-), TLR1(-/-) and wild-type mice. Interestingly, the population of E. coli in colonic luminal contents, intestinal permeability to FITC-dextran and cytokine expression were significantly increased in TLR1(-/-) and TLR2(-/-) mice, while they were decreased in TLR6(-/-) mice. Conclusion: In contrast to TLR6, both TLR1 and TLR2 deficiencies increased intestinal inflammation, and the over-growth of C. albicans and E. coli populations in the colitis model, suggesting the involvement of TLR1 and TLR2 in epithelial homeostasis, and a role of TLR6 in increasing intestinal inflammation in response to pathogen-sensing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes

Victor Mercier, Valerie Letscher-Bru, Marie-Elisabeth Bougnoux, Laurence Delhaes, Francoise Botterel, Daniele Maubon, Frederic Dalle, Alexandre Alanio, Sandrine Houze, Eric Dannaoui, Carole Cassagne, Sophie Cassaing, Marie-Fleur Durieux, Arnaud Fekkar, Jean-Philippe Bouchara, Jean-Pierre Gangneux, Julie Bonhomme, Damien Dupont, Damien Costa, Boualem Sendid, Taieb Chouaki, Nathalie Bourgeois, Antoine Huguenin, Sophie Brun, Caroline Mahinc, Lilia Hasseine, Solene Le Gal, Anne-Pauline Bellanger, Eric Bailly, Florent Morio, Celine Nourrisson, Nicole Desbois-Nogard, Estelle Perraud-Cateau, Anne Debourgogne, Helene Yera, Laurence Lachaud, Milene Sasso

Summary: The study aimed to determine the epidemiological cut-off values (ECVs) of ten antifungal agents in a wide range of yeasts and Aspergillus spp. using gradient concentration strips. Retrospective collection of minimum inhibitory concentrations for various antifungal agents was done from 35 French microbiology laboratories between 2002 and 2020. The calculated ECVs can aid in interpreting minimum inhibitory concentrations and identifying non-wild type isolates.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Pharmacology & Pharmacy

In vitro and in vivo evaluation of a pH-, microbiota- and time-based oral delivery platform for colonic release

S. Moutaharrik, A. Maroni, C. Neut, C. Dubuquoy, L. Dubuquoy, A. Foppoli, M. Cerea, L. Palugan, F. Siepmann, J. Siepmann, A. Gazzaniga

Summary: A novel drug delivery system based on multiple drug release triggers was developed and evaluated for oral colon delivery, with a specific focus on inflammatory bowel disease (IBD) therapy. The system demonstrated pulsatile drug release in different release media and faster drug release in simulated colonic fluid with fecal bacteria from IBD patients. Promising results were observed in a preliminary rat study, indicating potential therapeutic effects on colitis progression and microbiota alteration.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2023)

Article Gastroenterology & Hepatology

Human Fecal Mucin Glycosylation as a New Biomarker in Inflammatory Bowel Diseases

Catherine Robbe Masselot, Camille Cordier, Benjamin Marsac, Maria Nachury, Renaud Leonard, Boualem Sendid

Summary: This study used mass spectrometry to analyze the fecal mucins of Crohn's disease patients and found a significant decrease in sialylated glycans compared to the control group. This may propose a new noninvasive tool for screening intestinal diseases.

INFLAMMATORY BOWEL DISEASES (2023)

Correction Immunology

Transmission of trained immunity and heterologous resistance to infections across generations ( 10.1038/s41590-021-01052-7, 2021)

Natalie Katzmarski, Jorge Dominguez-Andres, Branko Cirovic, Georgios Renieris, Eleonora Ciarlo, Didier Le Roy, Konstantin Lepikhov, Kathrin Kattler, Gilles Gasparoni, Kristian Haendler, Heidi Theis, Marc Beyer, Jos W. M. van der Meer, Leo A. B. Joosten, Joern Walter, Joachim L. Schultze, Thierry Roger, Evangelos J. Giamarellos-Bourboulis, Andreas Schlitzer, Mihai G. Netea

NATURE IMMUNOLOGY (2023)

Article Oncology

Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity

Marc Pfefferle, Irina L. Dubach, Raphael M. Buzzi, Elena Duerst, Nadja Schulthess-Lutz, Livio Baselgia, Kerstin Hansen, Larissa Imhof, Sandra Koernig, Didier Le Roy, Thierry Roger, Rok Humar, Dominik J. Schaer, Florence Vallelian

Summary: The study revealed that CD40 signaling in Clec4f(+) Kupffer cells triggers anti-CD40 antibody-induced liver toxicity. However, controlled erythrophagocytosis and the linked anti-inflammatory signaling by the endogenous metabolite heme can be exploited to reprogram liver macrophages and prevent necroinflammatory liver disease caused by high-dose administration of anti-CD40 antibodies.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Review Immunology

ss-D-Glucan Assay in the Cerebrospinal Fluid for the Diagnosis of non-cryptococcal Fungal Infection of the Central Nervous System: A Retrospective Multicentric Analysis and a Comprehensive Review of the Literature

Jeanne Bigot, Jordan Leroy, Taieb Chouaki, Laurence Cholley, Naike Bige, Marie-Dominique Tabone, Eolia Brissot, Sophie Thorez, Julien Maizel, Herve Dupont, Boualem Sendid, Christophe Hennequin, Juliette Guitard

Summary: This study assessed the value of beta 1,3-D-glucan (BDG) detection in the cerebrospinal fluid (CSF) of non-neonatal non-cryptococcosis patients. The results showed that the sensitivity of BDG assay in diagnosing proven/highly probable/probable FI-CNS ranged from 72.7% to 100%, and the specificity was found to be 81.8%. Despite its sub-optimal performance, BDG assay should be added to the diagnostic armamentarium for FI-CNS.

CLINICAL INFECTIOUS DISEASES (2023)

Article Infectious Diseases

A rare case of presumptive pleural toxocariasis

Mickael Hirabidian, Saelens Thierry, Deleplancque Anne-Sophie, Benoit Bergues, Severine Loridant, Marjorie Cornu, Boualem Sendid, Jordan Leroy

Summary: This article describes a case of pleural fluid accumulation caused by Toxocara infection in a 72-year-old patient. The patient presented with symptoms such as dyspnea, fatigue, and diarrhea. Serological testing of both serum and pleural fluid confirmed the presence of anti-Toxocara antibodies. The symptoms were relieved after pleural drainage and treatment with anti-parasitic medication.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Time to intestinal clearance of carbapenemase- producing Enterobacterales in hospital patients: a longitudinal retrospective observational cohort study

N. Henoun Loukili, A. Loquet, A. Perrin, O. Gaillot, A. Bruandet, B. Sendid, J. R. Zahar, S. Nseir

Summary: This study aimed to evaluate the time to spontaneous CPE-IC and identify its potential associated risk factors. The median time to CPE-IC was 698 days. Female sex, multiple CPE-species, and E. coli or Klebsiella spp. infections were significantly associated with the time to CPE-IC. The presence of E. coli carbapenemase-producing or ESBL genes in index culture extended the median time to CPE-IC.

JOURNAL OF HOSPITAL INFECTION (2023)

Editorial Material Immunology

Editorial: Beneficial and pathological roles of myeloid cells during COVID-19

Lokesh Sharma, Shaon Sengupta, Thierry Roger

FRONTIERS IN IMMUNOLOGY (2023)

Review Microbiology

Healthy Diet and Lifestyle Improve the Gut Microbiota and Help Combat Fungal Infection

Samir Jawhara

Summary: Western diets, high in fat and sugar and low in vegetable fiber, are causing an increase in obesity and diseases of civilization. These diets lead to gut dysbiosis and overgrowth of Candida albicans, a major cause of fungal infection worldwide. Factors such as smoking, excessive alcohol consumption, lack of physical activity, prolonged use of antibiotics, and chronic psychological stress also contribute to disease development and gut dysbiosis. A diversified diet containing vegetable fiber, omega-3 polyunsaturated fatty acids, vitamins D and E, and probiotic or prebiotic supplements can improve the biodiversity of the microbiota and reduce the abundance of fungal species in the gut. Traditional medicine offers various foods and plants effective against fungal overgrowth and gut dysbiosis. Overall, healthy diets and lifestyle factors positively impact the gut microbiota and the brain.

MICROORGANISMS (2023)

Editorial Material Microbiology

Human Pathogenic Fungi: Host-Pathogen Interactions and Virulence

Samir Jawhara

MICROORGANISMS (2023)

Review Microbiology

What Is New in Pulmonary Mucormycosis?

Francois Danion, Anne Coste, Coralie Le Hyaric, Clea Melenotte, Frederic Lamoth, Thierry Calandra, Dea Garcia-Hermoso, Vishukumar Aimanianda, Fanny Lanternier, Olivier Lortholary

Summary: Mucormycosis is a rare and life-threatening fungal infection caused by molds of the order Mucorales. It mainly affects the lungs, following the rhino-orbito-cerebral (ROC) areas and the skin. Risk factors for pulmonary mucormycosis (PM) include hematological malignancies and solid organ transplantation, while ROC infections are commonly associated with diabetes mellitus. The diagnosis of PM relies on CT scans, cultures, PCR tests, and histology, and treatment involves liposomal amphotericin B as the first-line therapy.

JOURNAL OF FUNGI (2023)

Article Biochemistry & Molecular Biology

An extended transcription factor regulatory network controls hepatocyte identity

Julie Dubois-Chevalier, Celine Gheeraert, Alexandre Berthier, Clemence Boulet, Vanessa Dubois, Loic Guille, Marie Fourcot, Guillemette Marot, Karine Gauthier, Laurent Dubuquoy, Bart Staels, Philippe Lefebvre, Jerome Eeckhoute

Summary: Cell identity is controlled by a core transcriptional regulatory circuitry (CoRC) consisting of cell-specific transcription factors (TFs). However, our study reveals that the transcriptional regulatory network regulating hepatocyte identity is more complex than initially thought. We identified a set of TFs, which we call hepatocyte identity (Hep-ID)(CONNECT) TFs, that not only control hepatocyte identity effector genes, but also interact with TFs of the CoRC. Furthermore, we found that Hep-IDCONNECT TFs play a role in fine-tuning CoRC TF expression and can reset CoRC TF expression in dedifferentiated hepatocytes.

EMBO REPORTS (2023)

Article Chemistry, Medicinal

Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target

Morgane Rivoal, Laurent Dubuquoy, Regis Millet, Natascha Leleu-Chavain

Summary: RIPK2 is an essential downstream signaling molecule that activates various immune receptors, playing a crucial role in the release of pro-inflammatory cytokines. It has emerged as a potential therapeutic target for inflammatory diseases and cancer. This Perspective provides an overview of RIPK2 function, its role in diseases, available inhibitors, therapeutic strategies, and current challenges and outlook.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Infectious Diseases

Natural Compounds with Antifungal Properties against Candida albicans and Identification of Hinokitiol as a Promising Antifungal Drug

Louis Camaioni, Bastien Ustyanowski, Mathys Buisine, Dylan Lambert, Boualem Sendid, Muriel Billamboz, Samir Jawhara

Summary: Candida albicans is a pathogenic yeast with increasing resistance to antifungal drugs. This study identified hinokitiol, a natural compound extracted from cypress wood, as showing excellent antifungal activity against C. albicans. Hi not only inhibited candida growth and biofilm formation, but also displayed anti-inflammatory effects against lipopolysaccharide-induced cytokine expression in macrophages.

ANTIBIOTICS-BASEL (2023)

暂无数据